Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 18/20 | 0.68 |
| ▸ | PIK3R1 | P27986 | 8/20 | 0.64 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.64 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.64 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.64 |
| ▸ | MTOR | P42345 | 15/20 | 0.63 |
| ▸ | RPTOR | Q8N122 | 6/20 | 0.63 |
| ▸ | MLST8 | Q9BVC4 | 6/20 | 0.63 |
| ▸ | RICTOR | Q6R327 | 4/20 | 0.52 |
| ▸ | MAPKAP1 | Q9BPZ7 | 4/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16612087 | 1.00 | PIK3CA (0.68) | PIK3CAPIK3R1PIK3CDPIK3CBPIK3CG | |
| SCHEMBL16727878 | 0.89 | PIK3CA (0.63) | PIK3CAPIK3R1PIK3CDPIK3CBPIK3CG | |
| SCHEMBL16611585 | 0.87 | PIK3CA (0.76) | PIK3CAPIK3R1PIK3CDPIK3CBPIK3CG | |
| SCHEMBL16611584 | 0.87 | PIK3CA (0.76) | PIK3CAPIK3R1PIK3CDPIK3CBPIK3CG | |
| SCHEMBL16611305 | 0.86 | PIK3CA (0.81) | PIK3CAPIK3R1PIK3CDPIK3CBPIK3CG | |
| SCHEMBL16727875 | 0.83 | PIK3CA (0.68) | PIK3CAPIK3R1MTORRPTORMLST8 | |
| SCHEMBL16727847 | 0.82 | PIK3CA (0.83) | PIK3CAPIK3R1PIK3CDPIK3CBPIK3CG | |
| SCHEMBL19216954 | 0.82 | PIK3CA (0.54) | PIK3CAPIK3R1PIK3CDPIK3CBPIK3CG | |
| SCHEMBL16611392 | 0.81 | PIK3CA (1.00) | PIK3CAPIK3R1PIK3CDPIK3CBPIK3CG | |
| SCHEMBL16611391 | 0.81 | PIK3CA (1.00) | PIK3CAPIK3R1PIK3CDPIK3CBPIK3CG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2857403-B1 | PYRROLO[2,1-F][1,2,4]TRIAZINE COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF | SHANGHAI INST MATERIA MEDICA CAS (CN) | 2018-10-10 | — | — | EP | disclosed |
| US-9447101-B2 | Pyrrolo[2,1-f][1,2,4]triazine compound, and preparation method and application thereof | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2016-09-20 | — | — | US | disclosed |
| US-20150141644-A1 | PYRROLO[2,1-F][1,2,4]TRIAZINE COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2015-05-21 | — | — | US | disclosed |
| EP-2857403-A1 | PYRROLO[2,1-F][1,2,4]TRIAZINE COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF | Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) | 2015-04-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150141644-A1 | PYRROLO[2,1-F][1,2,4]TRIAZINE COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF | PIK3CA, PIK3R5, PIP4K2B | PIK3CA 1/4885PIK3R1 18/4885PIK3CD 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.